We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
+21.94%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
+$128M
Cap. Flow
+$26.2M
Cap. Flow %
2.17%
Top 10 Hldgs %
56.76%
Holding
362
New
28
Increased
88
Reduced
207
Closed
28

Top Buys

Rank Stock Value
1
TME icon
Tencent Music
TME
+$28.3M
2
LEGN icon
Legend Biotech
LEGN
+$20.2M
3
TCOM icon
Trip.com Group
TCOM
+$16M
4
STAA icon
STAAR Surgical
STAA
+$10.7M
5
ZLAB icon
Zai Lab
ZLAB
+$7.74M

Top Sells

Rank Stock Value
1
BEKE icon
KE Holdings
BEKE
+$21.9M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.8M
3
NIO icon
NIO
NIO
+$10.3M
4
LI icon
Li Auto
LI
+$8.53M
5
BZ icon
Kanzhun
BZ
+$8.18M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.91%
2 Technology 25.51%
3 Communication Services 14.94%
4 Healthcare 9.44%
5 Real Estate 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCL icon
151
Royal Caribbean
RCL
$78.7B
$452K 0.04%
9,137
– –
BAC icon
152
Bank of America
BAC
$435B
$448K 0.04%
13,513
-514
-4% -$17.7K
ALKS icon
153
Alkermes
ALKS
$8.82B
$447K 0.04%
17,116
-2,723
-14% -$65.2K
ISEE
154
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$447K 0.04%
20,879
-4,745
-19% -$101K
APLS
155
DELISTED
Apellis Pharmaceuticals
APLS
$445K 0.04%
8,604
+1,554
+22% +$82.4K
NTRA icon
156
Natera
NTRA
$37.5B
$445K 0.04%
11,083
+2,081
+23% +$85.7K
DHR icon
157
Danaher
DHR
$135B
$442K 0.04%
1,879
-122
-6% -$28.3K
FOLD
158
DELISTED
Amicus Therapeutics
FOLD
$442K 0.04%
36,161
-5,551
-13% -$62.5K
IRWD icon
159
Ironwood Pharmaceuticals
IRWD
$611M
$442K 0.04%
35,685
-7,619
-18% -$86.4K
XEL icon
160
Xcel Energy
XEL
$51B
$440K 0.04%
6,281
-260
-4% -$17.3K
PRTA icon
161
Prothena Corp
PRTA
$458M
$436K 0.04%
7,243
-86
-1% -$5.04K
ALNY icon
162
Alnylam Pharmaceuticals
ALNY
$36.3B
$434K 0.04%
1,828
-306
-14% -$65.3K
SWTX
163
DELISTED
SpringWorks Therapeutics
SWTX
$434K 0.04%
16,705
-98
-0.6% -$2.42K
MSI icon
164
Motorola Solutions
MSI
$69.4B
$433K 0.04%
1,682
– –
NBIX icon
165
Neurocrine Biosciences
NBIX
$17.7B
$431K 0.04%
3,606
-867
-19% -$102K
EXEL icon
166
Exelixis
EXEL
$13.9B
$430K 0.04%
26,803
+192
+0.7% +$3.13K
BMRN icon
167
BioMarin Pharmaceuticals
BMRN
$11.5B
$428K 0.04%
4,131
-995
-19% -$93.4K
IONS icon
168
Ionis Pharmaceuticals
IONS
$9.35B
$426K 0.04%
11,272
+1,102
+11% +$46.4K
HALO icon
169
Halozyme
HALO
$9.72B
$423K 0.04%
7,427
-4,078
-35% -$209K
PTCT icon
170
PTC Therapeutics
PTCT
$6.37B
$423K 0.04%
11,083
+2,202
+25% +$91.5K
RXDX
171
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$422K 0.04%
3,836
-2,696
-41% -$175K
KRTX
172
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$421K 0.04%
2,143
+229
+12% +$49.1K
UTHR icon
173
United Therapeutics
UTHR
$26.3B
$419K 0.03%
1,508
-623
-29% -$157K
DNLI icon
174
Denali Therapeutics
DNLI
$3.67B
$413K 0.03%
14,861
+607
+4% +$18.1K
ANSS
175
DELISTED
Ansys
ANSS
$411K 0.03%
1,702
-1
-0.1% -$233
5 6
7
8 9

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

E Fund Management's Q4 2022 Portfolio in Review

As of Q4 2022, E Fund Management held 362 positions worth $1.2B, up 12% from $1.07B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

E Fund Management's Q4 2022 filing shows 28 new, 88 increased, 207 reduced and 28 closed positions. Its largest new stake was Akero Therapeutics: 9,604 shares worth $526K. The largest sale was KE Holdings, an estimated $21.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 37% of assets, up from 34% a quarter earlier, followed by Technology and Communication Services.

  • E Fund Management's largest Q4 2022 buy was Akero Therapeutics: 9,604 shares worth $526K.
  • E Fund Management added most to Tencent Music in Q4 2022, an estimated $28.3M increase.
  • E Fund Management's biggest Q4 2022 reduction was KE Holdings, cutting an estimated $21.9M.
  • E Fund Management fully exited Li Auto in Q4 2022, selling an estimated $8.53M.
  • E Fund Management's ten largest holdings make up 57% of its $1.2B portfolio in Q4 2022.
  • E Fund Management opened 28 new positions and closed 28 in Q4 2022.
  • E Fund Management's portfolio value rose 12% quarter-over-quarter to $1.2B.

Based on E Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.